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Risk and Value Judgments:




How much cost or inconvenience should be put upon one person to
reduce the risk of harm or even death to another? Kristin Shrader-
Frechette states that the task of risk analysis is to help us discover:1
how safe is safe enough;
how much we ought to pay for safety;
how equitably we ought to distribute societal risks; and
how reliable are our scientific measures of risk.
Legislators, regulators and others avoid directly addressing such
questions, but they are woven throughout safety regulation. They are
often disguised or hidden to keep people from seeing the difficult policy
issues. As discussed recently by Julie Roqu6, a popular way to disguise
policy issues is with a technical cloak.2 Because it is widely perceived
that risk management questions can be determined precisely and
conclusively, answers are believed to reflect "scientific truth."
Yet, the very act of deciding which questions to ask involves any
number of value judgments, and ultimate answers reflect those inherent
judgments. Moreover, as addressed in a growing body of literature,
* Mr. Hilton has a B.S. in Electrical Engineering and a B.A. in Computer Science
from Tufts University. He also has a J.D. from Franklin Pierce Law Center and
presently practices law in Boston.
1 K. SHRADER-FRECHETTE, RISK ANALYSIS AND SCIENTIFIC METHOD:
METHODOLOGICAL AND ETHICAL PROBLEMS WrIH EVALUATING SOCIETAL HAZARDS, 3
(1985).
2 Regulating Air Toxics in Rhode Island: Policy v. Technical Decisions, 2 RISK:
TSSUESIN HEALIH& SAFETY 123 (1991).
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attempts to seek answers to the questions eventually selected are apt to
involve a number of methodological assumptions.3
One difficulty with many such discussions is that supporting
illustrations involve sufficiently sophisticated technical and economic
issues that the initiated are soon lost. In an attempt to avoid such
problems, this paper considers the subject of child-resistant packaging,
a topic with which every reader is presumed to have had first hand
experience. It is also one relatively free of difficulties such as attempting
to evaluate human risk based on toxicological studies of other species.
Moreover, it is a topic under present regulatory scrutiny.
This discussion is in three parts. First, it considers the history and
key provisions of the Poison Prevention Packaging Act (PPPA).4
Second, it discusses implementing regulations, accomplishments under
them and proposed regulatory amendments. Finally, it will identify
some of the policy questions that should be explicitly addressed in
considering those proposals.
The Poison Prevention Packaging Act
Basic Provisions
The PPPA was proposed by Senator Frank Moss of Utah in 1969
and was enacted in 1970.5 It requires toxic substances intended for
3 See L. CLARK, ACCEPTABLERISK? MAKING DEcIsIONS 1NA TOxIcENVIRONMENT
(1989); S. KRIMSKY & A. PLOUGH, ENVIRONMENTAL HAZARDS: COMMUNICATING RISKS
AS A SOCIAL PROCESS (1988); SCIENCE POLICY, ETHICS, AND ECONOMIC
MTHODOLOGY: SOME PROBLEMS OF TECHNOLOGY ASSESSMENT AND ENVIRONMENTAL-
IMPACr ANALYSIS (1985); C. WHIPPLE & V. COVELLO. RISK ANALYSIS IN THE PRIVATE
SECTOR (1985); R. WALLER & V. COVELLO, LOW-PROBABIL1TY/HGH-CONSEQUENCE
RISK ANALYSIS: ISSUES, METHODS AND CASE STUDIES (1984); COVELLO, FLAMM,
RODRICKS & TARDIFF, THE ANALYSIS OF ACTUAL VERSUS PERCEIVED RISKS (1983);
KAHNEMAN SLOVIC & TVERSKY, JUDGMENT UNDER UNCERTAINTY: HEURISTICS AND
BIAS (1982); C. HOHENEMSER & J. KASPERSON, RISK IN THE TECHNOLOGICAL SOCIMTY
(1982); J. CONRAD, SOCIETY, TECHNOLOGY, AND RISK ASSESSMENT (1980); and
FISCHOFF, SLOVIC & LICHTENSTEIN, FACTS AND FEARS IN SOCIAL RISK ASSESSMENT
(1970).
4 15 U.S.C. §§ 1471-1476, Pub. L. 91-601, §§ 2-7, Dec. 30, 1970, 84 Stat.
1670-73. [Hereinafter, statutory references to 15 U.S.C. unless otherwise indicated.]
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use in the home to be packaged so as to exclude children under five
years of age. One of its most significant provisions defines "special
packaging" as:6
packaging that is designed or constructed to be significantly
difficult for children under five years of age to open or
obtain a toxic or harmful amount of the substance contained
herein within a reasonable time and not difficult fdr normal
adults to use properly, but does not mean packaging which
all such children cannot open or obtain a toxic or harmful
amount within a reasonable time. [Emphasis added.]
Such packaging of household substances is required when it is
found that:7
(1) the degree or nature of the hazard to children in the
availability of such substance, by reason of its packaging, is
such that special packaging is required to protect children
from serious personal injury or serious illness resulting from
handling, using, or ingesting such substance; and
(2) the special packaging to be required by such standard is
technically feasible, practicable, and appropriate for such
substance. [Emphasis added.]
Attention is also to be given to (1) the reasonableness of the
standard; (2) technical data; (3) the manufacturing practices of affected
industries; and (4) the nature and use of the household substance. 8
The Most Controversial Aspect of the Legislation
The major controversy raised during consideration of the PPPA was
not the characteristics of special packaging but whether it was to be the
rule or the exception, i.e., whether consumers should have to seek out
special packaging or whether they would have to seek out conventional
packaging.
The Senate passed a bill calling for noncomplying packages being
available in a single size upon request.9 In contrast, the House Report
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cited census figures indicating that approximately 75% of households in
the U.S. did not have children between the ages of one and five and
called for child-resistant packages to be the exception. 10 The Report
stated that "it seems illogical.., to require that all sizes of a substance
except one be marketed in special packaging when 3 out of 4
households do not have children in such age groups."'11
The Senate view prevailed, and the PPPA provides that
noncomplying packages may be made available in a single size if the
product is also available in special packages and the noncomplying
packages bear the the label "This package for households without young
children." 12 Also, noncomplying packages for prescription drugs are
available on request. 13
Administration of the Act
The Regulations
When the PPPA was enacted, its implementation was given to the
Secretary of Health, Education and Welfare and, ultimately, to the Food
and Drug Administration (FDA). It required the Secretary to establish a
technical advisory committee of not more than eighteen members
collectively representing the Departments of Commerce and Health,
Education and Welfare, manufacturers of both substances and
packaging, consumers, scientists and medical practitioners. 14
Following a study conducted by Dr. Wilton Krogman and the
assistance of the advisory committee, the FDA adopted specifications
for special packaging and a testing protocol. 15
9 1970 U.S. Code Cong. and Adm. News. 5329-5331.
10 1970 U.S. Code Cong. and Adm. News. 5326-5328.
11 1970 U.S. Code Cong. and Adm. News. 5328.
12 § 1473.
13 § 1473(b).
14 The provision was repealed by the Budget Reconciliation Act of 1981, 38 Pub.
L. 97-35.
15 Supra note 4, at 83.
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Special packaging must meet the following specifications: 16
(1) Child-resistant effectiveness of not less than 85
percent without a demonstration and not less than 80
percent after a demonstration of the proper means of
opening such special packaging....
(2) Adult-use effectiveness of not less than 90 percent.
[Emphasis added.]
The testing protocol provides: 17
(1) Use 200 children between the ages of 42 and 51
months [3.5 to 4.25 years] inclusive, evenly distributed by
age and sex. ... The even age distribution shall be
determined by having 20 children (plus or minus 12 percent)
whose nearest age is 42 months [3.5 years], 20 whose
nearest age is 43 months [3.583 years], 20 at 44 months
[3.666 years], etc., up to and including 20 at 51 months of
age [4.25 years]. There should be no more than a 10 percent
preponderance of either sex in each age group. The children
selected should be healthy and normal and should have no
obvious or overt physical or mental handicap.
(2) The children shall be divided into groups of two
each. The testing shall be done in a location that is familiar to
the children.... Each child shall be allowed up to 5 minutes
to open the special packaging. For those children unable to
open the special packaging after the first 5 minutes, a single
visual demonstration without verbal explanation, shall be
given by the demonstrator. A second 5 minutes shall then be
allowed for opening the special packaging.... If a child fails
to use his teeth to open the special packaging during the first
5 minutes, the demonstrator shall instruct him, before the
start of the second 5 minute period, that he is permitted to
use his teeth if he wishes....
(4) One hundred adults, ages 18 to 45 years inclusive,
with no overt physical or mental handicaps, and 70 percent
of whom are female, shall comprise the test panel for normal
adults. ... The adults shall receive only printed instructions
... as will appear on the package ... Five minutes shall be
allowed to complete the opening, and if appropriate, the
resecuring process.
16 16 C.F.R. § 1700.15.
17 16 C.F.R. § 1700.20(a).
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The Reported Effect of the Act
In 1972, when the Consumer Product Safety Commission (CPSC)
was created as an independent regulatory commission, the PPPA was
transferred to it.18
In January 1990, a CPSC staff report disclosed a statistically
significant decrease in fatalities among children under age five from
accidental ingestions of prescriptions drugs coincidental with the
institution of the special packaging rules. The report, based on an
analysis of prescription drug data from 1964 to 1986, concluded that
special packaging for prescription drugs19 may have prevented an
estimated 340 fatalities between 1974 (when the regulations went into
effect) and 1986.20
Yet special packaging is not the sole factor in reducing serious
consequences of accidental poisonings. Consider the following
examples. Children's aspirin, once the leading cause of accidental
poisonings, 21 currently enjoys a much smaller market, in part because
of the threat of Reye's syndrome.22 More young children are in day
care facilities (that arguably pose less such risk than the typical home).
Also, fewer accidental ingestions may be the result of increased
awareness of the problem, e.g., through annual observance of Poison
Prevention Week.
In fact, during Poison Prevention Week in March 1990, CPSC
Chairman Jacqueline Jones-Smith reminded consumers of the
importance of storing hazardous substances out of reach of children.
She indicated that, during 1987 alone, more than 30 children under five
18 P.L. 92-573, 86 Stat 1231.
19 This is, of course, but one of the many types of product posing a hazard. In
1962 alone, 450 children under the age of five died from accidental poisonings.
20 44 Consumer Prod. Safety Guide (CCH), January 11, 1990, at 3.
21 Federal Hazardous Substances Act: Hearings on S.2162, Before the Consumer
Subcomm. of the Senate Comm. on Commerce, 91st Cong., 1st Sess., at 161
(referring to Poison Control Center Data).
22 See, e.g., Public Citizen Health Research Group v. FDA, 740 F.2d 21 (D.C.
Cir. 1984).
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had died and another 100,000 had received hospital emergency room
treatment after accidentally swallowing medicines or household
chemicals.23
Worse, some of these may be caused by use of the term "poison
prevention" rather than "child resistance." As previously mentioned, the
margin for error is not large. Under the best of circumstances, special
packaging can be breached by 15-20% of children under the age of five
within ten minutes. 24 An adult not knowing this may be less diligent
than warranted.
Also, of course, if packaging is too difficult for adults, they may
purchase products in conventional containers, repackage them or fail to
resecure special packaging. This problem more than any other has led to
reconsideration of the regulations originally promulgated by the FDA.
Proposed Revisions to the Regulations
In January 1983, the CPSC published an advance notice of
proposed rule making, stating that "Since the existing requirements were
developed before the widespread use of such packaging, there may be
ways to improve their effectiveness and efficiency." 2 5 It also observed
that:26
... Information now available, including recent consumer
surveys, reveals that many consumers find child-resistant
packaging to be either too difficult or too inconvenient to
use. When given the choice, therefore, many consumers
purchase products in conventional rather than child-resistant
packaging. Consumers are also making a substantial number
of child-resistant packages ineffecive after bringing them
home. [Notes omitted.]
However, not until October 1990 were proposed rules published for
comment.2 7 Comments were originally to be submitted by January 3,
23 45 Consumer Prod. Safety Guide (CCH-), March 29, 1990, at 2.
24 Supra note 15.
25 48 F.R. 2389.
26 Id.
27 55 F.R. 40856.
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1991, but the time was subsequently extended to July 1.28
Six proposed amendments would address: (a) sequential testing of
smaller groups of children, (b) reducing ten children's test age groups to
three, (c) preventing variability in child and adult testing through site
and tester requirements, (d) refining the determination of whether adults
properly resecure special packages after opening them, (e) standardizing
test instructions, and (f) using a older adult test panel and shortened test
times.29 Effective dates for compliance with any adopted changes are
also proposed. 30
The last is .the most complex and potentially far reaching. As
proposed, it would change the last part of the regulation quoted above,
at note 17, to read:31
(4) (i) Younger adult panel. One hundred adults, age 18
to 45 years inclusive, with no overt physical or mental
handicaps, and 70 percent of whom are female, shall
comprise the test panel for younger adults.(ii) Older adult panel. One hundred adults, age 60 to
75 years inclusive, with no overt physical or mental
handicaps, and 70 percent of whom are female, shall
comprise the test panel for older adults. Only persons who
can open conventional (not child-resistant) snap and
continuous-threaded type plastic closures in a 1-minute
screening test shall be selected for the older adult panel. The
screening tests for this purpose shall use snap and
continuous- threaded (CT) plastic closures having a diameter
of 28 mm ± 18%, the CT closures having been resecured 72
hours before testing at 10 torque-inch-pounds, and round
plastic containers, in sizes of 2 ounce ± 1/2 ounce for the CT
type closure and 8 drams ± 4 drams for the snap type
closure.
(iii) Test procedures. The adults shall be tested
individually, rather than in groups of two or more. The
adults shall receive only such printed instructions on how to
28 56 F.R. 9181.
29 55 F.R. 40857-40863
30 55 F.R. 40863.
31 55 FR. 40865.
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open and properly secure the special packaging as will
appear on the package as it is delivered to the consumer.
Prior to the timed test, the adults shall be given a 30-second
period to attempt to become familiar with how the package
works, during which time they may read the instructions and
attempt to open the package. The regulations establishing
child-resistant standards for particular substances shall
specify which of the following times shall be allowed to
complete the opening and, if appropriate, the resecuring
process.
(A) For the younger adult panel (§ 1700.20(a)
(4)(i)), 30 seconds.
(B) For the younger adult panel (§ 1700.20(a)(4)(i)), 5 minutes.
(C) For the older adult panel (§ 1700.20(a)
(4)(ii)), 1 minute.
(D) For the older adult panel (§ 1700.20(a)
(4)(ii)), 5 minutes.
However the discussion considers several alternatives combining the
idea of substituting or supplementing the present adult panel32 with that
for shorter test times.33
Policy Issues and Value Judgments
From the beginning, special packaging has attracted criticism. Even
with the able and youthful adult test panel specified in the present
regulations, as many as one in ten subjects may be excluded for over
five minutes. In retrospect, it should not be surprising that some fraction
of those adults take measures to avoid such inconvenience. This was
recognized as early as 1980,34 and a 1989 CPSC study of children
treated for ingestion of medications revealed that 44% of consumed
prescription drugs (40% overall) were not dispensed in child-resistant
packaging. Also, it was found that products originally dispensed in
32 Note that the gender allocation remains the same; see 55 F.R. 40862.
33 55 F.R. 40861.
34 The quotation supra at note 24 cites an August 1980 report entitled, A Pilot
Study of Effectiveness and Functionality of Child-Resistant Containers and Related
User Attitudes as authority.
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child-resistant containers were obtained by children getting into, e.g.,
improperly secured original containers or conventional containers to
which the contents had been transferred. 35
Assuming that options are available, adults should not be
unnecessarily forced to choose between packaging that is difficult for
them and packaging that is not difficult for children. The use of
conventional packaging substitutes one kind of inconvenience for
another, an inconvenience that may be acute - particularly where
potentially harmful substances are medicines beside a sick bed or where
children are only rarely present. If containers are both child resistant
and easier for adults to use, obviously more adults will use them and
everyone will benefit.
The PPPA requirements for containers that, on the one hand,
exclude "not all" young children "for a reasonable time" and, on the
other, are "not difficult" for "normal" adults to use properly pose a great
number of factual issues.
The definition of "normal" adult is value laden, but it can be
considered in factual terms, i.e., however defined, what fraction of the
adult population is excluded? What level of what kinds of difficulty will
what fraction of the remaining "normal" adults tolerate under what
circumstances? Depending on the answers to those further questions,
how many adults (with children at least occasionally in their homes) will
fail to take measures adequate to prevent a child from getting into some
harmful substance? 3 6 To what extent is adult tolerance of
inconvenience a function of the nature of a particular substance? For
example, would adults be more tolerant of difficult drain cleaner
packaging than of analgesic packaging? 37 How many adults using
35 Schacter, Unintentional Ingestions of Medications by Children Under 5 Years of
Age [January-March 1989] (1990). The study is discussed in a bit more detail at 55
F.R. 40860.
36 However, it is clear that some attention has been given to such matters; see
supra note 30.
37 While 15 U.S.C. § 1472(b)(4) appears to give CPSC the power to discriminate
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child-resistant packaging would take additional measures if they knew
that up to 20% of children under the age of five can get into it within ten
minutes? 38
On the other side of the ledger, how much difficulty will children
tolerate to get into something that can cause them harm? For what
products will they expend greater effort? Should the testing protocol
evaluate only empty, unmarked containers or ones containing candy and
having attractive labels? 39 At what age does the risk diminish; what
role does, e.g., intelligence play? How many children, if given a
chance, will persist for greater than ten minutes? What are their
characteristics? What are the characteristics of those tending to succeed
most quickly? What role should that play in setting child effectiveness
specifications?
Some of those issues are highly normative, as is, e.g., the question
of whether children should be urged to use their teeth.4 0 But, perhaps
the key normative issue is: How much money should Congress provide
to answer these and similar questions without CPSC's having to resort
to, at best, incomplete data collected by emergency room personnel?
With more information, it might be easier to choose among options.
But lack of information does not excuse failure to consider a broader
range of choice. While the CPSC proposes to improve adult
accessibility, it fails directly to address inherent tradeoffs between adult
and juvenile accessibility to harmful substances. It mentions containers
with increased child resistance and adult utility but does not propose
increasing child resistance. 4 1 Nor does it consider, should that be
along these lines, it is not apparent that it has done so.
38 See 16 C.F.R. § 1700.20(a)(2) quoted supra note 17.
39 Neither the present nor the proposed protocol contemplates any such thing. See
55 F.R. 40866, setting forth proposed standardized child test instructions. Yet, 15
U.S.C. § 1472(d) gives authority to prohibit packages that might be attractive to
children.
40 See proposed instruction 25 at 55 F.R. 40866. See also proposed instruction
27, cautioning subjects not to try to open such packages at home.
41 55 F.R. 40863, indicating that at least some packaging is now available with
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necessary for certain types of packaging, compromises.
Consider, for example, a container that would exclude "only" 10%
of tested adults (however that group might be defined) after two
minutes while 99% of children under the age of five would be excluded
for ten minutes and 95% would be excluded for fifteen minutes.
Should the package be permitted? Under the present protocol that
container would be acceptable, but under the proposed protocol it would
not be. Given the current state of knowledge, however the issue is
characterized, it is difficult to call it "technical."
It may well be that the abilities of illiterate older adults are simply too
similar to those of bright, strong children to enable distinguishing the
two populations. If this is so, the bulk of these proposals represent
nothing more than value judgments in a technical cloak.
Conclusion
Most risk management concerns potential hazards where risk is
difficult to assess without training well beyond that of the average
citizen, and it is easy for ultimate issues to be obscured by intervening
technical questions. This is not the case for child resistant packaging.
Typical adults can understand juvenile and adult measurements of
packaging difficulty. Moreover, they should be aware that, once the
options are laid out, setting respective specifications of difficulty for
those populations is not, under the present state of knowledge, a task
calling for technical expertise.
Technical questions posed in the proposed amendments to PPPA
regulations should not be allowed to dominate the agenda. If they are
permitted to do so, this would offer little hope for areas that are far more
technically complex.
97% effectiveness in restricting child access and permitting 60-75 year old adults
access within one minute.
